TY - JOUR
T1 - Corticotropin-releasing factor receptor 1 in mouse spleen
T2 - Expression after immune stimulation and identification of receptor-bearing cells
AU - Radulovic, Marko
AU - Dautzenberg, Frank M.
AU - Sydow, Sabine
AU - Radulovic, Jelena
AU - Spiess, Joachim
PY - 1999/3/1
Y1 - 1999/3/1
N2 - A specific polyclonal Ab against the N-terminal domain of corticotropin- releasing factor (CRF) receptor, type 1 (CRF-R1), was employed to an immunohistochemical analysis of the spleen from naive mice and mice exposed to an immune challenge. Cell types stained with anti-CRF-R1 Ab were identified by their nuclear shapes and colocalization with the cell type- specific markers ER-MP58, ER-MP20, Moma-1, Moma 2, anti-CD3e mAbs, and anti- Ig Ab. Only a few clusters of CRF-R1+ cells were found in spleen sections of naive mice at sites typical for granulopoietic islands. However, a 17-fold increase in the mean number of CRF-R1+ cells was noted within hours following a challenge of acute systemic inflammation induced by i.p. administration of LPS. The majority of these cells were identified as mature neutrophils. CRF-R1 was shown to mediate suppression of the IL-1β secretion by these cells. However, at later time points a large number of granulocyte- macrophage precursors was strongly labeled with anti-CRF-R1 Ab. Western blot analysis of splenic membranes from animals treated with LPS revealed a m.w. of approximately 70,000 for CRF-R1. Subcellular staining patterns were suggestive for the predominant localization of CRF-R1 on granule membranes. CRF-R1 mRNA was detected in spleen but not in bone marrow and peripheral blood leukocytes from naive mice. Thus, it was indicated that CRF-R1 was not produced constitutively by mature or immature neutrophils. Its production was rather triggered by inflammatory stimuli.
AB - A specific polyclonal Ab against the N-terminal domain of corticotropin- releasing factor (CRF) receptor, type 1 (CRF-R1), was employed to an immunohistochemical analysis of the spleen from naive mice and mice exposed to an immune challenge. Cell types stained with anti-CRF-R1 Ab were identified by their nuclear shapes and colocalization with the cell type- specific markers ER-MP58, ER-MP20, Moma-1, Moma 2, anti-CD3e mAbs, and anti- Ig Ab. Only a few clusters of CRF-R1+ cells were found in spleen sections of naive mice at sites typical for granulopoietic islands. However, a 17-fold increase in the mean number of CRF-R1+ cells was noted within hours following a challenge of acute systemic inflammation induced by i.p. administration of LPS. The majority of these cells were identified as mature neutrophils. CRF-R1 was shown to mediate suppression of the IL-1β secretion by these cells. However, at later time points a large number of granulocyte- macrophage precursors was strongly labeled with anti-CRF-R1 Ab. Western blot analysis of splenic membranes from animals treated with LPS revealed a m.w. of approximately 70,000 for CRF-R1. Subcellular staining patterns were suggestive for the predominant localization of CRF-R1 on granule membranes. CRF-R1 mRNA was detected in spleen but not in bone marrow and peripheral blood leukocytes from naive mice. Thus, it was indicated that CRF-R1 was not produced constitutively by mature or immature neutrophils. Its production was rather triggered by inflammatory stimuli.
UR - http://www.scopus.com/inward/record.url?scp=0033105675&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033105675&partnerID=8YFLogxK
M3 - Article
C2 - 10072553
AN - SCOPUS:0033105675
SN - 0022-1767
VL - 162
SP - 3013
EP - 3021
JO - Journal of Immunology
JF - Journal of Immunology
IS - 5
ER -